Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histomonas meleagridis cell surface protein HP3.1 is an immunogenic protein localized to the outer membrane of the protozoan parasite Histomonas meleagridis, the etiological agent of histomonosis (blackhead disease) in poultry. This protein has been identified through comparative surfaceome and immunoproteome analyses as a key factor in host-parasite interactions, particularly in the colonization of the cecal mucosa and subsequent invasion of the liver. While related homologs like Hmp31 in other parabasalids primarily function as hydrogenosomal ADP/ATP carriers, they frequently exhibit moonlighting roles on the cell surface where they mediate adhesion to host tissues. HP3.1 is a primary candidate for the development of recombinant vaccines, as it elicites a significant humoral immune response in its main hosts, turkeys and chickens. The identification of such surface targets is increasingly important for the poultry industry following the international ban on effective but toxic chemotherapeutic agents like nitarsone and nitroimidazoles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histomonas meleagridis cell surface protein HP3.1 (HP3.1).